DEERFIELD, Ill.– Walgreens is now administering an additional dose of Pfizer and Moderna COVID-19 vaccine to certain immunocompromised individuals, following Food and Drug Administration (FDA) Emergency Use Authorization and new guidance from the Centers for Disease Control and Prevention (CDC). Individuals recommended for additional vaccination include those who are moderately to severely immunocompromised including people undergoing cancer treatment, stem cell or organ transplant recipients, people living with HIV or those who are receiving immunosuppressive treatments.

“Walgreens is committed to administering COVID-19 vaccines to our most vulnerable populations as quickly and safely as possible,” said Kevin Ban, Walgreens chief medical officer. “As one of the first companies to begin providing these vaccines, we have an experienced team of pharmacists and technicians, as well as the infrastructure to support the increased demand for these vaccines.”

Same-day appointments will be available on a walk-in basis at a select Walgreens stores. Patients should bring their vaccination record to appointments and will be required to attest to their eligibility.

The additional dose of COVID-19 vaccine should be the same vaccine as the initial series, when possible, and administered at least four weeks after completing the primary regimen. Patients must be 18 or older to receive the Moderna vaccine, or 12 and older to receive the Pfizer vaccine.

Walgreens has administered more than 30 million COVID-19 vaccines across long-term care facilities and in stores. To protect the health and safety of team members and customers, the company recently reinstated guidelines requiring all team members to wear face covers and encourages all customers, including those who are vaccinated, to wear face covers in its stores to help limit the spread of COVID-19.

More information on Walgreens efforts to support communities during the COVID-19 pandemic is available here.